MHeNs School for Mental Health and Neuroscience

The principal focus of the School for Mental Health and Neuroscience, abbreviated as (‘MHeNs’) is to conduct high-impact translational neuroscience research on neurological and psychiatric illness as well as mental health, and to provide state-of-the-art education to Master and PhD students. To this end, MHeNs brings together basic and clinical neuroscience domains in translational focus areas and expert groups. This enables maximum synergy between research groups across its current three divisions, optimizing the use of available expertise, and forging alignment of animal models and human research projects.

Annual Report 2018

The MHeNs Annual Report 2018 is now ready for browsing and download. We have again provided an overview of the research programmes within the three divisions and selected some highlights of our research and outreach activities and of the MHeNs educational programme. We hope that you will enjoy reading about our innovative translational research in neurological and sensory disorders and in mental health.

Knowledge Synthesis Nutrition and Mental Health

A consortium of researchers from Maastricht University (NUTRIM, MHeNs, EPP) and the Open University in Heerlen reviewed and synthesized the scientific knowledge on the relation between nutrition and mental disorders across the life span. The aim of this synthesis was to provide an overview of the scientific evidence on the relation between nutrition (dietary patterns and nutrients) and mental disorders, to identify knowledge gaps and to provide recommendations for practice and further research. The Dutch language report of this knowledge synthesis is now available.

Read more.

International conference "MDC1A: the road to therapy"

The international conference “MDC1A, the road to therapy” (Maastricht November 15-17, 2019), was a huge success. Experts from America, the United Kingdom, Italy, Sweden and Switzerland, among others, met to share their research, improve care and develop therapies for patients with the very rare (only around 20 patients known so far in the Netherlands) and as yet incurable muscle disease MDC1A (www.mdc1a.com).

More information.

Positive effect of medicine on neuropathic pain disorder

Researchers at the Maastricht UMC+ have shown that lacosamide has a positive effect in patients with small fiber neuropathy, a condition causing continuous neuropathic pain. The medicine reduced pain, improved sleep and had a positive effect on the overall wellbeing. The results were previously published in the journal Brain. Bianca de Greef obtained her PhD in small fiber neuropathy.

More information.

1
2
3
4